$1.27
2.42% yesterday
Nasdaq, Sep 05, 10:03 pm CET

Pacific Biosciences of California, Inc. Stock price

$1.27
-0.15 10.56% 1M
-0.07 5.22% 6M
-0.56 30.60% YTD
-0.13 9.29% 1Y
-4.05 76.13% 3Y
-5.20 80.37% 5Y
-3.44 73.04% 10Y
-15.17 92.27% 20Y
Nasdaq, Closing price Fri, Sep 05 2025
+0.03 2.42%

Key metrics

Basic
Market capitalization
$381.5m
Enterprise Value
$713.2m
Net debt
$331.7m
Cash
$314.7m
Shares outstanding
300.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.4 | 2.4
EV/Sales
4.6 | 4.4
EV/FCF
negative
P/B
6.2
Financial Health
Equity Ratio
40.2%
Return on Equity
-61.2%
ROCE
-71.3%
ROIC
-114.2%
Debt/Equity
10.5
Financials (TTM | estimate)
Revenue
$156.1m | $162.1m
EBITDA
$-174.9m | $-108.5m
EBIT
$-546.0m | $-520.4m
Net Income
$-526.4m | $-452.1m
Free Cash Flow
$-157.3m
Growth (TTM | estimate)
Revenue
-17.4% | 5.3%
EBITDA
40.0% | 56.6%
EBIT
-77.8% | -94.2%
Net Income
-31.5% | -45.9%
Free Cash Flow
39.7%
Margin (TTM | estimate)
Gross
24.0%
EBITDA
-112.0% | -66.9%
EBIT
-349.8%
Net
-337.2% | -278.8%
Free Cash Flow
-100.8%
More
EPS
$-1.8
FCF per Share
$-0.5
Short interest
16.0%
Employees
575
Rev per Employee
$270.0k
Show more

Is Pacific Biosciences of California, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Pacific Biosciences of California, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

10x Buy
53%
9x Hold
47%

Analyst Opinions

19 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

Buy
53%
Hold
47%

Financial data from Pacific Biosciences of California, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
156 156
17% 17%
100%
- Direct Costs 119 119
15% 15%
76%
37 37
24% 24%
24%
- Selling and Administrative Expenses 135 135
21% 21%
87%
- Research and Development Expense 97 97
43% 43%
62%
-175 -175
40% 40%
-112%
- Depreciation and Amortization 371 371
2,237% 2,237%
238%
EBIT (Operating Income) EBIT -546 -546
78% 78%
-350%
Net Profit -526 -526
31% 31%
-337%

In millions USD.

Don't miss a Thing! We will send you all news about Pacific Biosciences of California, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pacific Biosciences of California, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer
Neutral
Seeking Alpha
29 days ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.
Positive
The Motley Fool
30 days ago
PACB Sales Up 11%
More Pacific Biosciences of California, Inc. News

Company Profile

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christian Henry
Employees 575
Founded 2000
Website www.pacb.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today